[Salmonelloses in a psychiatric clinic. A 2 year study].
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001434:Bacteriophage Typing; D002353:Carrier State; D002701:Chloramphenicol / Q000627:therapeutic use; D007464:Clioquinol / Q000627:therapeutic use; D003428:Cross Infection; D004196:Disease Outbreaks; D004197:Disease Reservoirs; D004352:Drug Resistance, Microbial; D005260:Female; D005516:Food Microbiology; D006778:Hospitals, Psychiatric; D006801:Humans; D008460:Meat; D010276:Parasympatholytics / Q000627:therapeutic use; D010618:Phenanthrolines / Q000627:therapeutic use; D012475:Salmonella / Q000187:drug effects* / Q000302:isolation & purification; D012478:Salmonella Food Poisoning / Q000209:etiology; D012480:Salmonella Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control; D013557:Switzerland; D014871:Water Microbiology; D014876:Water Pollution
D000900:Anti-Bacterial Agents; D010276:Parasympatholytics; D010618:Phenanthrolines; D002701:Chloramphenicol; D007464:Clioquinol
Salmonellosen in einer psychiatrische Klinik. Eine zweijährige Untersuchungsstudie.